Literature DB >> 28459282

Use of Nasal High Flow in Stable COPD: Rationale and Physiology.

Lara Pisani1, Maria Laura Vega2.   

Abstract

High-flow nasal cannula (HFNC) is a device able to deliver heated and humidified oxygen at high flows (up to 60 L/minutes). Potential benefits of HFNC are several and include the improvement of lung mucociliary clearance, the washout of upper airway dead space, the generation of a low level of positive airway pressure (PEEP effect), the decrease in inspiratory resistance and at the same time the increase in expiratory resistance. The present review aimed to describe the evidence surrounding the use of HFNC in stable chronic obstructive pulmonary disease patients.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; chronic respiratory failure; high flow nasal cannula; oxygen therapy

Mesh:

Substances:

Year:  2017        PMID: 28459282     DOI: 10.1080/15412555.2017.1315715

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  14 in total

Review 1.  Clinical Evidence of Nasal High-Flow Therapy in Chronic Obstructive Pulmonary Disease Patients.

Authors:  Judith Elshof; Marieke L Duiverman
Journal:  Respiration       Date:  2020-01-28       Impact factor: 3.580

2.  Feasibility of Using Daily Home High-Flow Nasal Therapy in COPD Patients Following a Recent COPD Hospitalization.

Authors:  Gerard J Criner; Lii-Yoong H Criner; Sheril A George; Jiji K Thomas; Michael R Jacobs
Journal:  Chronic Obstr Pulm Dis       Date:  2022-01-27

3.  Additional Expiratory Resistance Elevates Airway Pressure and Lung Volume during High-Flow Tracheal Oxygen via Tracheostomy.

Authors:  Guang-Qiang Chen; Xiu-Mei Sun; Yu-Mei Wang; Yi-Min Zhou; Jing-Ran Chen; Kun-Ming Cheng; Yan-Lin Yang; Jian-Xin Zhou
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

4.  Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: a preliminary study.

Authors:  Nuttapol Rittayamai; Prapinpa Phuangchoei; Jamsak Tscheikuna; Nattakarn Praphruetkit; Laurent Brochard
Journal:  Ann Intensive Care       Date:  2019-10-22       Impact factor: 6.925

5.  High-Flow Nasal Cannula for Chronic Obstructive Pulmonary Disease with Acute Compensated Hypercapnic Respiratory Failure: A Randomized, Controlled Trial.

Authors:  Xu-Yan Li; Xiao Tang; Rui Wang; Xue Yuan; Yu Zhao; Li Wang; Hai-Chao Li; Hui-Wen Chu; Jie Li; Wen-Ping Mao; Yu-Jun Wang; Zhan-Hong Tian; Jian-Hua Liu; Qin Luo; Bing Sun; Zhao-Hui Tong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-24

Review 6.  Use of nasal high flow oxygen during acute respiratory failure.

Authors:  Jean-Damien Ricard; Oriol Roca; Virginie Lemiale; Amanda Corley; Jens Braunlich; Peter Jones; Byung Ju Kang; François Lellouche; Stefano Nava; Nuttapol Rittayamai; Giulia Spoletini; Samir Jaber; Gonzalo Hernandez
Journal:  Intensive Care Med       Date:  2020-09-08       Impact factor: 17.440

7.  Evaluation by various methods of the physiological mechanism of a high-flow nasal cannula (HFNC) in healthy volunteers.

Authors:  Miyuki Okuda; Nobuya Tanaka; Kazuyuki Naito; Takao Kumada; Koji Fukuda; Yuto Kato; Yuto Kido; Yutaro Okuda; Ryuji Nohara
Journal:  BMJ Open Respir Res       Date:  2017-07-20

8.  High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease.

Authors:  Rosa Di Mussi; Savino Spadaro; Tania Stripoli; Carlo Alberto Volta; Paolo Trerotoli; Paola Pierucci; Francesco Staffieri; Francesco Bruno; Luigi Camporota; Salvatore Grasso
Journal:  Crit Care       Date:  2018-08-02       Impact factor: 9.097

9.  High-Flow Nasal Cannula Oxygen Therapy Can Be Effective for Patients in Acute Hypoxemic Respiratory Failure with Hypercapnia: a Retrospective, Propensity Score-Matched Cohort Study.

Authors:  SooHyun Bae; Minkyu Han; Changyoung Kim; Hyeji Lee; Jong Joon Ahn; Jin Hyoung Kim; Byung Ju Kang
Journal:  J Korean Med Sci       Date:  2020-03-16       Impact factor: 2.153

10.  Nasal High Flow at 25 L/min or Expiratory Resistive Load Do Not Improve Regional Lung Function in Patients With COPD: A Functional CT Imaging Study.

Authors:  Julien G Cohen; Ludovic Broche; Mohammed Machichi; Gilbert R Ferretti; Renaud Tamisier; Jean-Louis Pépin; Sam Bayat
Journal:  Front Physiol       Date:  2021-06-10       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.